Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer

Breast cancer is the most common female cancer, affecting approximately one in eight women during their lifetime in North America and Europe. Receptor Activator of NF-kB Ligand (RANKL), its receptor RANK and the natural antagonist osteoprotegerin (OPG) are essential regulators of bone resorption. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kiechl, Stefan, Schramek, Daniel, Widschwendter, Martin, Fourkala, Evangelia-Ourania, Zaikin, Alexey, Jones, Allison, Jaeger, Bernadette, Rack, Brigitte, Janni, Wolfgang, Scholz, Christoph, Willeit, Johann, Weger, Siegfried, Mayr, Agnes, Teschendorff, Andrew, Rosenthal, Adam, Fraser, Lindsay, Philpott, Susan, Dubeau, Louis, Keshtgar, Mohammed, Roylance, Rebecca, Jacobs, Ian J., Menon, Usha, Schett, Georg, Penninger, Josef M.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354797/
https://ncbi.nlm.nih.gov/pubmed/28002811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados